Refine
Year of publication
Document Type
- Contribution to a Periodical (474)
- Article (37)
- Review (10)
- Preprint (5)
- Conference Proceeding (1)
Has Fulltext
- yes (527) (remove)
Is part of the Bibliography
- no (527) (remove)
Keywords
- Angiogenesis (2)
- Wound healing (2)
- aging (2)
- 3years (1)
- ALK-rearranged NSCLC (1)
- Acute kidney injury (1)
- Antirheumatic agents (1)
- Blood loss (1)
- COVID-19 (1)
- CVD biomarker (1)
Institute
- Präsidium (496)
- Gesellschaftswissenschaften (42)
- Neuere Philologien (41)
- Medizin (29)
- Biowissenschaften (12)
- Erziehungswissenschaften (12)
- Universitätsbibliothek (11)
- Physik (10)
- Rechtswissenschaft (10)
- Wirtschaftswissenschaften (8)
The directed and elliptic flow of protons and charged pions has been observed from the semi-central collisions of a 158 GeV/nucleon Pb beam with a Pb target. The rapidity and transverse momentum dependence of the flow has been measured. The directed flow of the pions is opposite to that of the protons but both exhibit negative flow at low pt. The elliptic flow of both is fairly independent of rapidity but rises with pt. PACS numbers: 25.75.-q, 25.75.Ld
Using the NA49 main TPC, the central production of hyperons has been measured in CERN SPS Pb - Pb collisions at 158 GeV c-1. The preliminary ratio, studied at 2.0 < y < 2.6 and 1 < pT < 3 GeV c-1, equals ~ (13 ± 4)% (systematic error only). It is compatible, within errors, with the previously obtained ratios for central S + S [1], S + W [2], and S + Au [3] collisions. The fit to the transverse momentum distribution resulted in an inverse slope parameter T of 297 MeV. At this level of statistics we do not see any noticeable enhancement of hyperon production with the increased volume (and, possibly, degree of equilibration) of the system from S + S to Pb + Pb. This result is unexpected and counterintuitive, and should be further investigated. If confirmed, it will have a significant impact on our understanding of mechanisms leading to the enhanced strangeness production in heavy-ion collisions.
Preliminary data on phi production in central Pb + Pb collisions at 158 GeV per nucleon are presented, measured by the NA49 experiment in the hadronic decay channel phi - K+K-. At mid-rapidity, the kaons were separated from pions and protons by combining dE/dx and time-of-flight information; in the forward rapidity range only dE/dx identification was used to obtain the rapidity distribution and a rapidity-integrated mt-spectrum. The mid-rapidity yield obtained was dN/dy = 1.85 ± 0.3 per event; the total phi multiplicity was estimated to be 5.0 ± 0.7 per event. Comparison with published pp data shows a slight, but not very significant strangeness enhancement.
The large acceptance TPCs of the NA49 spectrometer allow for a systematic multidimensional study of two-particle correlations in different part of phase space. Results from Bertsch-Pratt and Yano-Koonin-Podgoretskii parametrizations are presented differentially in transverse pair momentum and pair rapidity. These studies give an insight into the dynamical space-time evolution of relativistic Pb+Pb collisions, which is dominated by longitudinal expansion.
Lambda and Antilambda reconstruction in central Pb+Pb collisions using a time projection chamber
(1997)
The large acceptance time projection chambers of the NA49 experiment are used to record the trajectory of charged particles from Pb + Pb collisions at 158 GeV per nucleon. Neutral strange hadrons have been reconstructed from their charged decay products. To obtain distributions of Λ, and Ks0 in discrete bins of rapidity, y, and transverse momentum, pT, calculations have been performed to determine the acceptance of the detector and the efficiency of the reconstruction software as a function of both variables. The lifetime distributions obtained give values of cτ = 7.8 ± 0.6 cm for Λ and cτ = 2.5 ± 0.3 cm for Ks0, consistent with data book values.
Background: Juvenile dermatomyositis (JDM) is the most common inflammatory myopathy in childhood and a major cause of morbidity among children with pediatric rheumatic diseases. The management of JDM is very heterogeneous. The JDM working group of the Society for Pediatric Rheumatology (GKJR) aims to define consensus- and practice-based strategies in order to harmonize diagnosis, treatment and monitoring of JDM.
Methods: The JDM working group was established in 2015 consisting of 23 pediatric rheumatologists, pediatric neurologists and dermatologists with expertise in the management of JDM. Current practice patterns of management in JDM had previously been identified via an online survey among pediatric rheumatologists and neurologists. Using a consensus process consisting of online surveys and a face-to-face consensus conference statements were defined regarding the diagnosis, treatment and monitoring of JDM. During the conference consensus was achieved via nominal group technique. Voting took place using an electronic audience response system, and at least 80% consensus was required for individual statements.
Results: Overall 10 individual statements were developed, finally reaching a consensus of 92 to 100% regarding (1) establishing a diagnosis, (2) case definitions for the application of the strategies (moderate and severe JDM), (3) initial diagnostic testing, (4) monitoring and documentation, (5) treatment targets within the context of a treat-to-target strategy, (6) supportive therapies, (7) explicit definition of a treat-to-target strategy, (8) various glucocorticoid regimens, including intermittent intravenous methylprednisolone pulse and high-dose oral glucocorticoid therapies with tapering, (9) initial glucocorticoid-sparing therapy and (10) management of refractory disease.
Conclusion: Using a consensus process among JDM experts, statements regarding the management of JDM were defined. These statements and the strategies aid in the management of patients with moderate and severe JDM.
Vom 19. bis 21. September fand im Forschungskolleg Humanwissenschaften die bereits dritte Bad Homburg Conference statt. Die Konferenz zum Thema Künstliche Intelligenz brachte Perspektiven aus verschiedenen wissenschaftlichen Disziplinen und der Praxis zusammen. Referentinnen und Referenten u. a. aus Informatik, Rechtswissenschaft, Medizin, Philosophie und Hirnforschung diskutierten mit Vertretern der gesellschaftlichen Praxis: Unternehmern, Industrievertretern, einem Kriminalhauptkommissar des Landeskriminalamts Hessen und einer Bürgerrechtsaktivistin und Politikberaterin aus den USA. Begrüßt wurden die Teilnehmer von ForschungskollegDirektor Prof. Dr. Matthias Lutz-Bachmann, der Vizepräsidentin der Goethe-Universität, Prof. Dr. Simone Fulda, dem Bürgermeister der Stadt Bad Homburg, Meinhard Matern, sowie der Hessischen Ministerin für Digitale Strategie und Entwicklung, Prof. Dr. Kristina Sinemus. Der Abschlusskommentar kam von Christoph Burchard, Professor für Straf- und Strafprozessrecht, Internationales und Europäisches Strafrecht, Rechtsvergleichung und Rechtstheorie an der Goethe-Universität. Der UniReport hatte Gelegenheit, mit Christoph Burchard nach der Konferenz zu sprechen.
Introduction: The Retro-IDEAL (ILUVIEN Implant for chronic DiabEtic MAcuLar edema) study is a retrospective study designed to assess real-world outcomes achieved with the ILUVIEN® (0.19 mg fluocinolone acetonide (FAc)) in patients with chronic diabetic macular edema (DME) in clinical practices in Germany.
Methods: This study was conducted across 16 sites in Germany and involved 81 eyes (63 patients) with persistent or recurrent DME and a prior suboptimal response to a first-line intravitreal therapy (primarily anti-VEGF intravitreal therapies).
Results: Patients were followed-up for 30.8 ± 11.3 months (mean ± standard deviation) and had a mean age of 68.0 ± 10.4 years. Best-recorded visual acuity (BRVA) improved by +5.5 letters at month 9 (P ⩽ 0.005, n=56; from a baseline of 49 letters) and this was maintained through to month 30 (P ⩽ 0.05, n = 42). There was a concurrent improvement in central macular thickness with a reduction from 502 µm at baseline to 338 µm at year 1 (P ⩽ 0.0001, n = 43). This effect was sustained to year 3 (i.e. 318 µm; P ⩽ 0.0001, n = 29). Mean intraocular pressure (IOP) remained constant between baseline and year 3 with a peak change of 1.9 mm Hg occurring at year 1. Elevated IOP was observed in a similar percentage of patients prior to (22.2% of cases) and following (27.2%) treatment with the FAc implant. In the majority of cases, these elevations were managed effectively with IOP medications.
Conclusions: Despite substantial amounts of prior intravitreal treatments – primarily with anti–vascular endothelial growth factor (VEGF) drugs – this real-world study showed that sustained structural and functional improvements can last for up to 3 years with a single FAc implant.
In his widely acclaimed book “Das Kalte Herz” (The Cold Heart), economic historian Werner Plumpe tells the story of the history of capitalism, which in his view represents a sober form of economics which has proved itself superior and higher performing than other systems. To this day, the long tradition of capitalism criticism has not understood that in capitalism, great wealth is utilized to produce goods that are usually affordable for people with small incomes.
Die drei Journalisten Patrick Bauer, Patrick Illinger und Till Krause sind für das Süddeutsche Zeitung Magazin in einer tiefschürfenden Recherche dem Fall des Tübinger Professors Niels Birbaumer nachgegangen, der behauptete, die Gedanken von unheilbar an der Nervenkrankheit ALS leidenden Patienten entschlüsseln zu können. Dabei traten jedoch immer größer werdende Unstimmigkeiten zwischen Datenlage und öffentlichen Erfolgsmeldungen auf. Insbesondere die Daten, auf denen die vermeintlichen Forschungsergebnisse basierten, konnten bei Nachprüfungen von anderen Experten nicht nachvollzogen werden. Die Jury des Goethe-Medienpreises erkannte dieser auch journalistisch herausragend umgesetzten Arbeit den 1. Preis zu. Mit zwei Journalisten des Teams, mit Dr. Till Krause und Dr. Patrick Illinger, konnte der UniReport vor der Preisverleihung sprechen.
Motiviert für Tokio
(2021)